BNR Stock Analysis: Buy, Sell, or Hold?
BNR - Burning Rock Biotech Limited American Depositary Shares
$8.90
0.05 (0.56%)
▲
5d:
-0.56%
30d:
+6.33%
90d:
-45.2%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Sep 14, 2026
Get Alerted When BNR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BNR shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: BNR shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: BNR is currently trading at $8.90, which is considered slightly low relative to its 30-day fair value range of $8.51 to $10.57.
Technical Outlook: Technically, BNR is in a strong downtrend. The price is currently testing key support at $8.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $4.03. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BNR is in a strong downtrend. The price is currently testing key support at $8.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $4.03. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$8.51 -
$10.57
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 54.7% above Wall St target ($4.03)
Trading Range Analysis
30-Day Trading Range
$8.51 -
$10.57
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$8.70
Resistance Level
$10.10
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Wall Street Target
$4.03
(-54.7%)
Revenue Growth (YoY)
-18.9%
Profit Margin
-11.5%
Share & Embed Analysis
Last updated: August 02, 2026 12:47 PM ET
Data refreshes hourly during market hours. Next update: 1:47 PM
Data refreshes hourly during market hours. Next update: 1:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Yusheng Han
BUY
314870 shares
2026-03-31
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$630 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$188 | 61 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 59 HOLD |
